In neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, and multiple system atrophy, α-synuclein accumulates as modified protein aggregates that actively contribute to disease processes, including synaptic dysfunction, inflammation, and cell death4–8. Here, SNCA is linked to neurodegenerative disease.